Report Detail
Global Antidiabetics Market Professional Survey Report 2019
- RnM3792677 |
- 30 September, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
The global Antidiabetics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antidiabetics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antidiabetics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antidiabetics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antidiabetics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Other
Segment by Application
Hospital Use
Clinic Use
Household
Other
Table of Contents
Executive Summary
1 Industry Overview of Antidiabetics
- 1.1 Definition of Antidiabetics
- 1.2 Antidiabetics Segment by Type
- 1.2.1 Global Antidiabetics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Type 1 Diabetes
- 1.2.3 Type 2 Diabetes
- 1.2.4 Other
- 1.3 Antidiabetics Segment by Applications
- 1.3.1 Global Antidiabetics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital Use
- 1.3.3 Clinic Use
- 1.3.4 Household
- 1.3.5 Other
- 1.4 Global Antidiabetics Overall Market
- 1.4.1 Global Antidiabetics Revenue (2014-2025)
- 1.4.2 Global Antidiabetics Production (2014-2025)
- 1.4.3 North America Antidiabetics Status and Prospect (2014-2025)
- 1.4.4 Europe Antidiabetics Status and Prospect (2014-2025)
- 1.4.5 China Antidiabetics Status and Prospect (2014-2025)
- 1.4.6 Japan Antidiabetics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Antidiabetics Status and Prospect (2014-2025)
- 1.4.8 India Antidiabetics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Antidiabetics
- 2.3 Manufacturing Process Analysis of Antidiabetics
- 2.4 Industry Chain Structure of Antidiabetics
3 Development and Manufacturing Plants Analysis of Antidiabetics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Antidiabetics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Antidiabetics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Antidiabetics Production and Capacity Analysis
- 4.2 Antidiabetics Revenue Analysis
- 4.3 Antidiabetics Price Analysis
- 4.4 Market Concentration Degree
5 Antidiabetics Regional Market Analysis
- 5.1 Antidiabetics Production by Regions
- 5.1.1 Global Antidiabetics Production by Regions
- 5.1.2 Global Antidiabetics Revenue by Regions
- 5.2 Antidiabetics Consumption by Regions
- 5.3 North America Antidiabetics Market Analysis
- 5.3.1 North America Antidiabetics Production
- 5.3.2 North America Antidiabetics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Antidiabetics Import and Export
- 5.4 Europe Antidiabetics Market Analysis
- 5.4.1 Europe Antidiabetics Production
- 5.4.2 Europe Antidiabetics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Antidiabetics Import and Export
- 5.5 China Antidiabetics Market Analysis
- 5.5.1 China Antidiabetics Production
- 5.5.2 China Antidiabetics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Antidiabetics Import and Export
- 5.6 Japan Antidiabetics Market Analysis
- 5.6.1 Japan Antidiabetics Production
- 5.6.2 Japan Antidiabetics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Antidiabetics Import and Export
- 5.7 Southeast Asia Antidiabetics Market Analysis
- 5.7.1 Southeast Asia Antidiabetics Production
- 5.7.2 Southeast Asia Antidiabetics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Antidiabetics Import and Export
- 5.8 India Antidiabetics Market Analysis
- 5.8.1 India Antidiabetics Production
- 5.8.2 India Antidiabetics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Antidiabetics Import and Export
6 Antidiabetics Segment Market Analysis (by Type)
- 6.1 Global Antidiabetics Production by Type
- 6.2 Global Antidiabetics Revenue by Type
- 6.3 Antidiabetics Price by Type
7 Antidiabetics Segment Market Analysis (by Application)
- 7.1 Global Antidiabetics Consumption by Application
- 7.2 Global Antidiabetics Consumption Market Share by Application (2014-2019)
8 Antidiabetics Major Manufacturers Analysis
- 8.1 Sanofi-Aventis
- 8.1.1 Sanofi-Aventis Antidiabetics Production Sites and Area Served
- 8.1.2 Sanofi-Aventis Product Introduction, Application and Specification
- 8.1.3 Sanofi-Aventis Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Takeda Pharmaceuticals
- 8.2.1 Takeda Pharmaceuticals Antidiabetics Production Sites and Area Served
- 8.2.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
- 8.2.3 Takeda Pharmaceuticals Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Eli Lilly
- 8.3.1 Eli Lilly Antidiabetics Production Sites and Area Served
- 8.3.2 Eli Lilly Product Introduction, Application and Specification
- 8.3.3 Eli Lilly Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Oramed Pharmaceuticals
- 8.4.1 Oramed Pharmaceuticals Antidiabetics Production Sites and Area Served
- 8.4.2 Oramed Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Oramed Pharmaceuticals Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Boehringer Ingelheim
- 8.5.1 Boehringer Ingelheim Antidiabetics Production Sites and Area Served
- 8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.5.3 Boehringer Ingelheim Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Merck & Co. Inc.
- 8.6.1 Merck & Co. Inc. Antidiabetics Production Sites and Area Served
- 8.6.2 Merck & Co. Inc. Product Introduction, Application and Specification
- 8.6.3 Merck & Co. Inc. Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Novo Nordisk
- 8.7.1 Novo Nordisk Antidiabetics Production Sites and Area Served
- 8.7.2 Novo Nordisk Product Introduction, Application and Specification
- 8.7.3 Novo Nordisk Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Bristol-Myers Squibb
- 8.8.1 Bristol-Myers Squibb Antidiabetics Production Sites and Area Served
- 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.8.3 Bristol-Myers Squibb Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Halozyme Therapeutics
- 8.9.1 Halozyme Therapeutics Antidiabetics Production Sites and Area Served
- 8.9.2 Halozyme Therapeutics Product Introduction, Application and Specification
- 8.9.3 Halozyme Therapeutics Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Pfizer
- 8.10.1 Pfizer Antidiabetics Production Sites and Area Served
- 8.10.2 Pfizer Product Introduction, Application and Specification
- 8.10.3 Pfizer Antidiabetics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Antidiabetics Market
- 9.1 Global Antidiabetics Market Trend Analysis
- 9.1.1 Global Antidiabetics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Antidiabetics Regional Market Trend
- 9.2.1 North America Antidiabetics Forecast 2019-2025
- 9.2.2 Europe Antidiabetics Forecast 2019-2025
- 9.2.3 China Antidiabetics Forecast 2019-2025
- 9.2.4 Japan Antidiabetics Forecast 2019-2025
- 9.2.5 Southeast Asia Antidiabetics Forecast 2019-2025
- 9.2.6 India Antidiabetics Forecast 2019-2025
- 9.3 Antidiabetics Market Trend (Product Type)
- 9.4 Antidiabetics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Antidiabetics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Antidiabetics. Industry analysis & Market Report on Antidiabetics is a syndicated market report, published as Global Antidiabetics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Antidiabetics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
